Insider · CIK 0001584348

Barnes Alane P

Reports to the SEC for 1 company · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001584348

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-13	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+62.5K sh	$5.04	+$315K	463,203
2026-05-13	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−62.5K sh	$9.54	−$596K	400,703
2026-05-13	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−62.5K sh	—	—	0
2026-03-16	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+150K sh	$5.51	+$827K	550,703
2026-03-16	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−150K sh	$9.15	−$1.37M	400,703
2026-03-16	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−150K sh	—	—	0
2025-12-22	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−21.8K sh	$7.65	−$167K	398,751
2025-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−16.9K sh	$7.41	−$125K	420,524
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+122K sh	—	—	437,426
2025-12-17	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+255K sh	—	—	255,050
2025-12-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−21.2K sh	$7.65	−$162K	315,726
2025-12-12	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−8,540 sh	$7.57	−$64.6K	336,936
2025-12-03	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−19.8K sh	$7.65	−$151K	345,476
2025-12-02	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−50.9K sh	$7.21	−$367K	365,246
2025-12-01	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+91K sh	$3.22	+$293K	507,156
2025-12-01	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−91K sh	$7.10	−$647K	416,152
2025-12-01	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−91K sh	—	—	0
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+121K sh	—	—	415,190
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−2,461 sh	$7.39	−$18.2K	412,729
2024-12-19	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+250K sh	—	—	250,100
2024-12-14	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−8,613 sh	$7.53	−$64.9K	294,490
2024-05-13	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Chief Legal Officer	PPurchase	+5,000 sh	$5.53	+$27.7K	300,762
2023-12-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−2,482 sh	$6.05	−$15K	293,539
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+64K sh	—	—	300,036
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Legal Officer	FTax Payment	−4,015 sh	$6.43	−$25.8K	296,021
2023-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+159K sh	—	—	158,500
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+34K sh	—	—	232,770
2022-12-19	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+159K sh	—	—	158,500
2022-12-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−4,175 sh	$10.88	−$45.4K	198,770
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+75K sh	—	—	221,969
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+164K sh	—	—	164,000
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Legal Officer	AAward	+55K sh	—	—	201,969
2021-05-12	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+35.9K sh	$4.73	+$170K	146,127
2021-05-12	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−35.9K sh	—	—	0
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,648 sh	$4.73	+$7,795.04	111,923
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+33.1K sh	$1.42	+$47K	145,055
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+68K sh	$5.45	+$371K	213,055
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−103K sh	$12.04	−$1.24M	110,275
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,648 sh	—	—	35,852
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−33.1K sh	—	—	0
2021-05-11	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−68K sh	—	—	0
2020-12-15	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+280K sh	—	—	280,000
2020-12-11	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+13.7K sh	$4.15	+$57K	121,802
2020-12-11	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−13.7K sh	$7.96	−$109K	108,061
2020-12-11	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−13.7K sh	—	—	0
2020-12-04	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+13.7K sh	$4.15	+$57K	121,802
2020-12-04	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Legal Officer	SSale	−13.7K sh	$6.23	−$85.6K	108,061
2020-12-04	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−13.7K sh	—	—	13,741
2020-12-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+17K sh	—	—	17,000
2020-02-21	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+12.4K sh	—	—	12,400

Recent filings

Accepted (ET)
May 154
Barnes Alane P0000882796-26-000021
SEC(opens sec.gov)
Mar 184
Barnes Alane P0000882796-26-000015
SEC(opens sec.gov)
Dec 234
Barnes Alane P0000882796-25-000043
SEC(opens sec.gov)
Dec 194
Barnes Alane P0001171843-25-008037
SEC(opens sec.gov)
Dec 164
Barnes Alane P0000882796-25-000033
SEC(opens sec.gov)
Dec 34
Barnes Alane P0000882796-25-000027
SEC(opens sec.gov)
Dec 234
Barnes Alane P0001127602-24-029952
SEC(opens sec.gov)

Companies

BIOCRYST PHARMACEUTICALS INCChief Legal OfficerBCRX

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703